Chemical probes to spy on bacterial activity in real time
AI-generated hypothesis · Pre-publication · To be tested experimentally
Table of contents — full brief
- Hypothesis and mechanismCausal chain, key assumptions, residual unknowns
- State of the artVerified references and counter-evidence (DOIs)
- Falsifiable predictionsQuantitative bounds, statistical tests, H0
- Experimental protocolThree phases — in silico → minimal → full
- Impact analysisNovelty, residual gaps, available data
- Panel reviewFive personas + meta-review
Verified references
5 of 20 references- DOI: 10.1021/jacs.8b09668 ↗
A Probe-Enabled Approach for the Selective Isolation and Characterization of Functionally Active Subpopulations in the Gut Microbiome
2018 - DOI: 10.1038/nm.3929 ↗
In vivo imaging and tracking of host-microbiota interactions via metabolic labeling of gut anaerobic bacteria
2015 - DOI: 10.1016/J.CCLET.2021.03.056 ↗
Real-time identification of gut microbiota with aminopeptidase N using an activable NIR fluorescent probe
2021 - DOI: 10.1016/j.cbpa.2019.10.007 ↗
Activity-based protein profiling in bacteria: Applications for identification of therapeutic targets and characterization of microbial communities
2019 - DOI: 10.1021/cb3004995 ↗
d-Amino Acid Chemical Reporters Reveal Peptidoglycan Dynamics of an Intracellular Pathogen
2012
+ 15 more references
Detailed panel scores
A three-phase protocol (in silico, minimal, complex) is structured with clear GO/NO-GO/PIVOT criteria at each stage, permitting early termination and economical reallocation of resources.
The hypothesis consistently capitalises on robust, published proof-of-concept findings (ABPP for β-glucuronidase in [2018], metabolic labelling of Bacteroidales via fucose [2011]) to propose a generalisable platform, which represents a logical and desirable progression within the domain.
The conceptual approach of taxon-orthogonalised probes is elegant and addresses a genuine need in functional microbial ecology.
Immediate captive market: probiotic R&D companies (e.g., Enterome, Vedanta Biosciences, 4D Pharma) and microbiome-specialised CROs (e.g., Second Genome, Microbiome Insights) would pay for an in situ functional quantification tool, replacing costly metagenomic approaches that provide little information on actual activity.
A highly original and mechanistic hypothesis is presented, addressing a fundamental bottleneck in microbial ecology: the in situ quantification of functional activity, rather than merely taxonomic abundance. A strong potential for disruptive advance is indicated (TRL 2–3 towards 4–5).
Receive the next SPORE hypotheses
Once or twice a month, in your inbox. No spam, one-click unsubscribe.
Your data stays private. No third-party sharing. GDPR-compliant.